Brian Piekos serves as AMAG’s interim Chief Financial Officer. He joined AMAG in 2015 and has held a number of senior management positions with the Company. In his most recent role as Senior Vice President of Finance, Mr. Piekos has provided oversight of AMAG’s financial planning and reporting, tax, treasury and strategic sourcing processes. He has more than 20 years of corporate finance experience including strategic planning, financial reporting and capital market activities. Prior to joining AMAG, he held positions of increasing responsibility at Cubist Pharmaceuticals. Mr. Piekos began his career in investment banking having served as Vice President at Leerink Partners and as an analyst at Needham & Company. Mr. Piekos graduated from Ithaca College with B.A. in Biochemistry. He also received an M.S. in Molecular Biology from the University of Massachusetts Medical School and an MBA from University of Rochester’s Simon Business School.
As of November, 2020 AMAG Pharmaceuticals, Inc. is now a subsidiary of the Covis Pharma Group. For more information about Covis, please visit (covispharma.com)